4.7 Article

TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia

Related references

Note: Only part of the references are listed.
Review Oncology

Strategies for modern biomarker and drug development in oncology

Alan D. Smith et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)

Review Oncology

Selective inhibitors of nuclear export (SINE)- a novel class of anti-cancer agents

Kaushal Parikh et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)

Review Oncology

TIGAR, TIGAR, burning bright

Pearl Lee et al.

CANCER & METABOLISM (2014)

Article Cell Biology

TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis

Eric C. Cheung et al.

DEVELOPMENTAL CELL (2013)

Review Biochemistry & Molecular Biology

Cancer cell metabolism: implications for therapeutic targets

Miran Jang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2013)

Review Cell Biology

Links between metabolism and cancer

Chi V. Dang

GENES & DEVELOPMENT (2012)

Article Medicine, Research & Experimental

Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation

Sucheta Telang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Article Biochemistry & Molecular Biology

Detection of reactive oxygen species (ROS) by the oxidant-sensing probe 2′,7′-dichlorodihydrofluorescein diacetate in the cyanobacterium Anabaena variabilis PCC 7937

Rajesh P. Rastogi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

Karim Bensaad et al.